Lupkynis Європейський Союз - італійська - EMA (European Medicines Agency)

lupkynis

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - immunosoppressori - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).

RIMMUNOS Італія - італійська - AIFA (Agenzia Italiana del Farmaco)

rimmunos

biomedica foscama group s.p.a. - micofenolato mofetile - micofenolato mofetile